Company History, Founders

Prof. Camille-Georges Wermuth Pharm.D, PhD.

Prof. Camille-Georges Wermuth Pharm.D, PhD
  • Professor of Organic and Medicinal Chemistry at the Faculty of Pharmacy, University of Strasbourg
  • founded Prestwick Chemical Inc. in 1999 in which he acted as President and CSO
  • main research themes focus on the chemistry and the pharmacology of pyridazine derivatives, among them one can cite: antidepressant and anticonvulsant molecules
  • marketed drugs: Cantor® (antidepressant) , Junctum®, Cogitum® (analeptic)
  • 300 scientific papers and about 60 patents
  • co-author or editor of several books
  • president of the Medicinal Chemistry Section of the International Union of Pure and Applied Chemistry (IUPAC)
     

Dr. Kathleen Clarence-Smith MD, PhD

Dr. Kathleen Clarence-Smith MD, PhD
  • internationally-recognized neurologist
  • developed new pharmaceuticals and shepherded them from early stages onto the market
  • senior positions in large pharmaceutical companies (Sanofi; Roche; Otsuka)
  • later founded, raised money and headed start-up pharmaceutical companies
  • founded Prestwick Holding and  Chemical Inc. in 1999 in which she acted as CEO
  • board certified neurologist for several companies
  • > 100 peer-reviewed papers
  • founder and a president of the American Society of Experimental NeuroTherapeutics (ASENT) and  member of several scientific societies